Cuprina to Acquire Seven-Clinic Singapore Healthcare Group

Biotechnology
Biotechnology
Acquisition
Acquisition
IPO:
Apr 10, 2025
Industry:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Show Chart?

Load external content from TradingView!

*You can change or withdraw your consent at any time in the footer under Cookies.

Cuprina to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group

Singapore, October 2, 2026 - Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR), a biomedical company, announced that it has entered into Sale and Purchase Agreements to acquire 100% of East Coast Podiatry Centre Pte. Ltd. and Orchard Clinic Management Pte. Ltd., operating a total of seven clinics in Singapore, for approximately S$4.0 million (US$3.1 million).

The acquisition combines S$3.0 million in cash and S$1.0 million in Class A ordinary shares of the Company. The target group generated unaudited revenue of approximately S$9.1 million and normalized EBITDA of approximately S$1.2 million for fiscal year 2025.

This strategic move integrates established clinical platforms directly aligned with Cuprina's wound-care and collagen technologies, expanding the company into an integrated healthcare platform.

Acquisition Highlights

  • Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics).
  • Total purchase consideration of approximately S$4.0 million.
  • Target group generated FY2025 unaudited revenue of S$9.1 million and normalized EBITDA of S$1.2 million.
  • Completion expected on or before November 1, 2026.

About Cuprina Holdings (Cayman) LTD

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https://www.cuprina.com.

View Company Details

More CUPR News

SPAC IPO Calendar
SPAC IPO Events
Scroll to Top